@article{c417c9b304b0402d93f9c3e8d6b047ca,
title = "Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers",
author = "McNeil, {Shelly A.} and Halperin, {Scott A.} and Langley, {Joanne M.} and Bruce Smith and Andrew Warren and Sharratt, {Geoffrey P.} and Baxendale, {Darlene M.} and Reddish, {Mark A.} and Hu, {Mary C.} and Stroop, {Steven D.} and Janine Linden and Fries, {Louis F.} and Vink, {Peter E.} and Dale, {James B.}",
note = "Funding Information: Potential conflicts of interest. S.A.M, S.A.H., J.M.L., B.S., G.P.S., A.W., and D.M.B. are clinical investigators at the Clinical Trials Research Centre at Dalhousie University and received financial support from the sponsor company, ID Biomedical, for the conduct of this trial; none of these investigators received personal compensation and none hold financial interests in the product. M.C.H., S.D.S., L.F.F., P.E.V., J.L., and M.A.R. are employed by the vaccine manufacturer and study sponsor, ID Biomedical, and own stock and/or stock options in ID Biomedical. J.B.D. is the inventor of the vaccine used in this study and receives research support from ID Biomedical; he owns stock and stock options in ID Biomedical and holds existing and pending patents related to the study product. Financial Support. ID Biomedical.",
year = "2005",
month = oct,
day = "15",
doi = "10.1086/444458",
language = "English",
volume = "41",
pages = "1114--1122",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "8",
}
